The projects of this laboratory aim to provide new chemical genetic tools to define, perturb and manipulate essential functions of the enzymes involving protein posttranslational modification (methyltransferases and acetyltransferases). Another focus in this laboratory is to design and synthesize tight-binding inhibitors as anti-cancer drug candidates by blocking these protein-modifying activities. Researchers in the field of chemistry, biology and biochemistry work together closely to synthesize novel chemical reagents, elucidate illness-causing mechanisms at molecular level and develop potential treatments for human diseases.

Office phone:
Laboratory phone:
Selected Achievements

Basil O'Connor Starter Scholar, March of Dimes Birth Defects Foundation (2011)

Director’s New Innovator Award, National Institutes of Health (2010)

Alfred W. Bressler Scholar, Alfred W. Bressler Scholars Endowment Fund (2010)

V Scholar Award, V Foundation for Cancer Research (2009)

Outstanding Postdoctoral Research Prize, Albert Einstein College of Medicine (2007)